Cigna Group $CI Shares Acquired by Wealthfront Advisers LLC

Wealthfront Advisers LLC increased its stake in Cigna Group (NYSE:CIFree Report) by 18.5% in the second quarter, HoldingsChannel.com reports. The firm owned 22,282 shares of the health services provider’s stock after acquiring an additional 3,482 shares during the quarter. Wealthfront Advisers LLC’s holdings in Cigna Group were worth $6,143,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Brighton Jones LLC grew its position in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the period. Sivia Capital Partners LLC lifted its position in shares of Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the period. NewEdge Advisors LLC boosted its stake in shares of Cigna Group by 4.5% during the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after acquiring an additional 958 shares in the last quarter. Treasurer of the State of North Carolina boosted its stake in shares of Cigna Group by 16.6% during the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock worth $49,204,000 after acquiring an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. acquired a new stake in shares of Cigna Group in the 2nd quarter worth approximately $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Down 1.1%

Shares of CI stock opened at $274.50 on Friday. The company has a market capitalization of $72.53 billion, a price-to-earnings ratio of 11.36, a PEG ratio of 0.95 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a 50-day moving average price of $284.63 and a 200 day moving average price of $281.41. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the company earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is 25.82%.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider owned 25,880 shares in the company, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 23,012 shares of company stock valued at $6,386,550 over the last ninety days. 0.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

CI has been the subject of several research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Jefferies Financial Group cut Cigna Group from a “buy” rating to a “hold” rating and dropped their price target for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Barclays increased their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Finally, Morgan Stanley raised their target price on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $339.45.

Get Our Latest Stock Report on Cigna Group

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.